Genia Turanova

Genia Turanova, Chief Investment Strategist for Game-Changing Stocks and Fast-Track Millionaire, is a financial writer and money manager whose experience includes serving for more than a decade as a portfolio manager and Investment Committee member for a New York-based money management firm.  Genia also researched, wrote and managed recommendations for several investment advisories. From 2011 to 2016, she served as Editor of the award-winning Leeb Income Performance newsletter. Genia also wrote for The Complete Investor, another award winner, from 2003 to 2016. During that time, Genia was responsible for several portfolios, including the "Income/Value" portfolio and the "FastTrack" portfolio. Genia's academic credentials include an MBA in Finance and Investments from the Zicklin School of Business, Baruch College in New York City. Genia is a CFA Charterholder.

Analyst Articles

There are many tools designed to help investors analyze their portfolio holdings and to ultimately weed out undesirable or riskier stocks. Financial analysis is always helpful, of course, but studying companies’ balance sheets and their filings requires a lot of time and effort. Financial… Read More

Last month, I ran a stock screen to see which companies seemed attractive to insiders in the month of September, with the market trading near its all-time highs. One stock from that screen has already made it to our portfolio — after doing further research, I added it in the latest issue of Game-Changing Stocks. —Recommended Link— Are you missing the mark when it comes to beating the market? Our newly released report “Top 10 stocks for 2019” is your definitive guide to beating the market in the coming year. Complete with 10 heavily researched stock picks… from multiple… Read More

Last month, I ran a stock screen to see which companies seemed attractive to insiders in the month of September, with the market trading near its all-time highs. One stock from that screen has already made it to our portfolio — after doing further research, I added it in the latest issue of Game-Changing Stocks. —Recommended Link— Are you missing the mark when it comes to beating the market? Our newly released report “Top 10 stocks for 2019” is your definitive guide to beating the market in the coming year. Complete with 10 heavily researched stock picks… from multiple sectors, this report could bring in hefty double-digit gains in 2019. Click here to discover the picks now. But as you know, in barely a month the market changed. October brought us nearly a 7% decline in the S&P 500, a 5% decline in the Dow Industrials, and a better than 9% decline in the Nasdaq Composite Index. #-ad_banner-#Last month’s screen showed us which stocks were considered bargains by insiders in a strong, climbing market. The same or similar methods should work with a weaker market, too. Therefore, I recently set out to determine which stocks are considered bargains by… Read More

The market is now well into a second month of higher volatility and declining prices. And if you feel that the recent volatility impacted our portfolio stocks disproportionally, you are correct. Our stocks, many of which have been market champions on the way up,… Read More

What a violent October we had in the market. And if that weren’t enough, we had the election to contend with to kick off November. —Recommended Link— “It’s like getting 26 paychecks advanced to you in ONE LUMP SUM!” Executive Dividends are one of Wall Street’s best-kept secrets, paying out a small fortune in unannounced cash seemingly at random–and today, Nathan Slaughter shows you where to find them. Read more here. Now that it’s all behind us, I hope neither of those things distracted you from what matters at least as much (perhaps more) — which is taking the… Read More

What a violent October we had in the market. And if that weren’t enough, we had the election to contend with to kick off November. —Recommended Link— “It’s like getting 26 paychecks advanced to you in ONE LUMP SUM!” Executive Dividends are one of Wall Street’s best-kept secrets, paying out a small fortune in unannounced cash seemingly at random–and today, Nathan Slaughter shows you where to find them. Read more here. Now that it’s all behind us, I hope neither of those things distracted you from what matters at least as much (perhaps more) — which is taking the long view on your portfolio. For my Fast-Track Millionaire subscribers and myself, that means doing the hard work of watching developments in the market’s fastest growing sectors and digging deeper to find ideas that can dramatically alter the trajectory of our portfolio. Take biotech for instance. This is an area that would have been easy to completely ignore during all the chaos and volatility of the past six weeks or so. But not us. Risk vs. Reward Biotechnology is risky, and so is investing in it. #-ad_banner-#These risks can be managed, but they can also be compounded. An example… Read More

  Last month, I ran a stock screen to see which companies seemed attractive to insiders in the month of September, with the market trading near its all-time highs. You can see it here. One stock from that screen, E. W. Scripps (Nasdaq: SSP), has already… Read More

A big disappointment came today from one of our Fast Revenue Growers portfolio holdings, internet marketer and insurance quote provider EverQuote (Nasdaq: EVER). The company’s quarterly guidance — which, for this young company, is the best way we have to judge whether or not… Read More

  As the market weakness continues, more stocks suffer but more buying opportunities are being created. One example: optical communications company Lumentum (Nasdaq: LITE), which lost nearly a third of its value today after reporting a “meaningful reduction” in the size of orders from a “major… Read More

Stock screens are a powerful tool. While they won’t serve as a substitute for full-fledged stock research, often they can provide a promising idea or two for a watch list. And many of those watch-list ideas can, in turn, become full-fledged recommendations. —Recommended Link— U.S. Army Invests In Real-Life Spiderman Suit (Not Kidding) It’s like something straight out of science-fiction… According to our research, the U.S. Army has invested in a small biotech company with a breakthrough technology using the DNA of spiders. We’re not kidding. Not only could it change the future of warfare — it has a… Read More

Stock screens are a powerful tool. While they won’t serve as a substitute for full-fledged stock research, often they can provide a promising idea or two for a watch list. And many of those watch-list ideas can, in turn, become full-fledged recommendations. —Recommended Link— U.S. Army Invests In Real-Life Spiderman Suit (Not Kidding) It’s like something straight out of science-fiction… According to our research, the U.S. Army has invested in a small biotech company with a breakthrough technology using the DNA of spiders. We’re not kidding. Not only could it change the future of warfare — it has a host of unique properties that could lead to a range of applications, allowing early investors to strike it rich. To get all the fascinating details, go here. The stock screen that follows seems to have generated at least a couple of such promising ideas. But let’s start at the beginning. To accommodate the mission of Fast-Track Millionaire — that is, finding stocks that can greatly outperform the market — I started this screen with the S&P 400 Mid-Cap index. Here’s How I Set Up This Screen As the name implies, the S&P 400 index was created specifically with mid-sized… Read More